Varenicline
Varenicline

2.1
Helps the process of reducing cravings associated with cessation programs.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Varenicline
Reference Brand
Chantix
Product Origin
Generic Product
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Addiction Recovery
Product Category
Nicotinic Receptor Partial Agonist
Pharmacological Class
Smoking Cessation Aid
Clinical Indications
Manufacturer Description
Indicated for smoking cessation to manage nicotine withdrawal and support tobacco abstinence.
Mechanism of Action
Varenicline acts as a partial agonist at alpha-4-beta-2 nicotinic acetylcholine receptors. It provides low-level stimulation to reduce withdrawal symptoms while blocking nicotine's ability to activate the receptors, diminishing the reward of smoking.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Hypersensitivity to varenicline
Severe Adverse Events
Neuropsychiatric events, Suicidal ideation, Angioedema — requires immediate medical attention
Common Side Effects
Nausea, Vivid dreams, Insomnia
Uncommon Side Effects
Headache, Constipation, Vomiting
Drug Interactions
Alcohol, Cimetidine, Warfarin, Insulin
Pregnancy Safety Warnings
FDA Category C: Use only if clearly needed. Breastfeeding: Not recommended.
Age Restrictions
Safety and efficacy in pediatric patients have not been established.
Storage Guidelines
Store at room temperature.
Related Products
Champix, Chantix, Zyban
Information related to Varenicline is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to access Contraceptives UK - Levonorgestrel Emergency Contraceptive